SALISBURY, MD / ACCESSWIRE / January 4, 2022 / The Drug Delivery Company, LLC, a research and development company that...
HACKENSACK, NJ / ACCESSWIRE / January 4, 2022 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading global technology-enabled biotech that is...
The Canalevia.com website, a resource for veterinarians and dog owners, is now liveCanalevia™-CA1 is the first and only treatment for...
ENGLEWOOD, CO / ACCESSWIRE / January 4, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's...
Key patent now granted in major markets including the U.S., Europe, Canada & South KoreaPatent claims cover use of the...
ENGLEWOOD, CO / ACCESSWIRE / January 4, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel...
RALEIGH, NC / ACCESSWIRE / January 4, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-stage company pioneering...
SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced today that Dr. Henry Ji,...
The collaboration will explore the uptake and actionability of comprehensive genomic profiling in patients with advanced cancersSAN FRANCISCO, Jan. 04,...
ARLINGTON, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will participate in...
Economic impact of COVID continuing to subside as Company expands operations in California LAS VEGAS, NV, Jan. 04, 2022 (GLOBE...
Media Release Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologiesGenmab secures rights for conducting research on ADCs against...
Boca Raton, Florida, Jan. 04, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing...
Dr. Yeu brings over 20 years of eye care experience, and is a highly regarded leader in clinical care and...
Racine, WI, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Renew Medical Aesthetics WI, a leading medical spa operating in Wisconsin, have...
BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the...
ISELIN, N.J., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch...
REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management...
WOBURN, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that...
BILLERICA, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will provide a business...